The role of positron emission tomography in management of small cell lung cancer

被引：32

作者：

Thomson, D. ^{[1
]}

Hulse, P. ^{[2
]}

Lorigan, P. ^{[3
]}

Faivre-Finn, C. ^{[1
]}

机构：

[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, Lancs, England

[2] Christie NHS Fdn Trust, Dept Radiol, Manchester M20 4BX, Lancs, England

[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England

来源：

LUNG CANCER | 2011年 / 73卷 / 02期

关键词：

Lung cancer; Small-cell lung cancer; Positron emission tomography; PET; FDG-PET; PET-CT; CLINICAL-PRACTICE GUIDELINES; PHASE-III TRIAL; BODY FDG-PET; RESPONSE EVALUATION; THORACIC RADIOTHERAPY; TNM-CLASSIFICATION; PROGNOSTIC-FACTORS; F-18-FDG PET; DIAGNOSIS; CT;

D O I：

10.1016/j.lungcan.2011.03.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Accurate radiological staging of small-cell lung cancer (SCLC) is of paramount importance in selection of individual patients with limited stage disease for potentially curative treatment while avoiding toxic treatment in those with distant metastatic disease. [F-18] flurodeoxy-o-glucose (FDG) positron emission tomography (PET) is an attractive tool for this purpose but there is limited evidence to support its use in the routine staging of SCLC. Whether therapeutic decisions based on FDG-PET imaging should be made remains uncertain. There is only preliminary evidence for use of FDG-PET as a prognostic biomarker, in the assessment of response to treatment and delineation of disease in conformal radiation planning. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：121 / 126

页数：6

共 50 条

[41] Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Skoura, Evangelia
Datseris, Ioannis E.
Platis, Ioannis
Oikonomopoulos, Georgios
Syrigos, Konstantinos N.
CLINICAL LUNG CANCER, 2012, 13 (03) : 181 - 187
[42] Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer
Hattori, Aritoshi
Matsunaga, Takeshi
Takamochi, Kazuya
Oh, Shiaki
Suzuki, Kenji
ANNALS OF THORACIC SURGERY, 2017, 103 (05): : 1614 - 1621
[43] Improvement of non-small-cell lung cancer staging by means of positron emission tomography
Albes, JM
Lietzenmayer, R
Schott, U
Schülen, E
Wehrmann, M
Ziemer, G
THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (01): : 42 - 47
[44] Prediction by positron emission tomography scanning of survival in non-small cell lung cancer
Dunagan, DM
Chin, R
Haponik, E
CHEST, 2001, 120 (06) : 2113 - 2113
[45] MEDIASTINAL STAGING OF NON-SMALL-CELL LUNG-CANCER WITH POSITRON EMISSION TOMOGRAPHY
CHIN, R
WARD, R
KEYES, JW
CHOPLIN, RH
REED, JC
WALLENHAUPT, S
HUDSPETH, AS
HAPONIK, EF
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) : 2090 - 2096
[46] Staging of non-small-cell lung cancer with positron-emission tomography.
Miller, YE
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21): : 1571 - 1572
[47] The accuracy of positron emission tomography in mediastinal staging of non-small cell lung cancer
Akpinar, Deniz
Ceylan, Kenan Can
Duman, Elif
Unsal, Saban
Kaya, Seyda Ors
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 21 (01): : 100 - 105
[48] Can positron emission tomography be used as a staging tool for small-cell lung cancer?
Vinjamuri, Mridula
Craig, Michael
Campbell-Fontaine, Annette
Almubarak, Mohammed
Gupta, Naresh
Rogers, John S.
CLINICAL LUNG CANCER, 2008, 9 (01) : 30 - 34
[49] 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer
Zhao, DSS
Valdivia, AY
Li, Y
Blaufox, MD
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) : 272 - 275
[50] The role of positron emission tomography for evaluation of lung nodules and staging lung cancer
Barbara M. Fischer
Jann Mortensen
Current Respiratory Care Reports, 2012, 1 (1): : 30 - 39

← 1 2 3 4 5 →